Mechanical Circulatory Support Devices for the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction-A Review

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Sep 9

PMID 36079170

Authors

Sharon Bruoha

Chaim Yosefy

Louay Taha

Danny Dvir

Mony Shuvy

Rami Jubeh

Shemy Carasso

Michael Glikson

Elad Asher

Affiliations

Soon will be listed here.

Abstract

Cardiogenic shock complicating acute myocardial infarction is a complex clinical condition associated with dismal prognosis. Routine early target vessel revascularization remains the most effective treatment to substantially improve outcomes, but mortality remains high. Temporary circulatory support devices have emerged with the aim to enhance cardiac unloading and improve end-organ perfusion. However, quality evidence to guide device selection, optimal installation timing, and post-implantation management are scarce, stressing the importance of multidisciplinary expert care. This review focuses on the contemporary use of short-term support devices in the setting of cardiogenic shock following acute myocardial infarction, including the common challenges associated this practice.

Citing Articles

Ventricular Septal Rupture as a Complication of Acute Myocardial Infarction: Clinical Characteristics and Prognostic Comparison of Different Treatment Methods.

He Z, Wang Z, Dong B, Long Q Anatol J Cardiol. 2025; .

PMID: 39763315 PMC: 11904253. DOI: 10.14744/AnatolJCardiol.2024.4674.

Lactate Monitoring in Intensive Care: A Comprehensive Review of Its Utility and Interpretation.

Deulkar P, Singam A, Mudiganti V, Jain A Cureus. 2024; 16(8):e66356.

PMID: 39246930 PMC: 11379417. DOI: 10.7759/cureus.66356.

Prognostic Value of the Advanced Lung Cancer Inflammation Index Ratio in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Cohort Study.

Gong M, Sasmita B, Zhu Y, Chen S, Wang Y, Xiang Z Rev Cardiovasc Med. 2024; 25(7):267.

PMID: 39139443 PMC: 11317351. DOI: 10.31083/j.rcm2507267.

Clinical implications of septic cardiomyopathy: A narrative review.

Hiraiwa H, Kasugai D, Okumura T, Murohara T Medicine (Baltimore). 2024; 103(17):e37940.

PMID: 38669408 PMC: 11049701. DOI: 10.1097/MD.0000000000037940.

Cardiogenic shock etiology and exit strategy impact survival in patients with Impella 5.5.

Sicke M, Modi S, Hong Y, Bashline M, Klass W, Horn E Int J Artif Organs. 2023; 47(1):8-16.

PMID: 38053245 PMC: 10824236. DOI: 10.1177/03913988231214180.

References

Amin A, Spertus J, Curtis J, Desai N, Masoudi F, Bach R . The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. Circulation. 2019; 141(4):273-284. DOI: 10.1161/CIRCULATIONAHA.119.044007. View

Thiele H, Sick P, Boudriot E, Diederich K, Hambrecht R, Niebauer J . Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26(13):1276-83. DOI: 10.1093/eurheartj/ehi161. View

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos J . Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock. Front Cardiovasc Med. 2021; 8:686558. PMC: 8292640. DOI: 10.3389/fcvm.2021.686558. View

Baran D, Grines C, Bailey S, Burkhoff D, Hall S, Henry T . SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the.... Catheter Cardiovasc Interv. 2019; 94(1):29-37. DOI: 10.1002/ccd.28329. View

Thiele H, Ohman E, de Waha-Thiele S, Zeymer U, Desch S . Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019; 40(32):2671-2683. DOI: 10.1093/eurheartj/ehz363. View

ONeill W, Grines C, Schreiber T, Moses J, Maini B, Dixon S . Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. 2018; 202:33-38. DOI: 10.1016/j.ahj.2018.03.024. View

van Diepen S, Katz J, Albert N, Henry T, Jacobs A, Kapur N . Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017; 136(16):e232-e268. DOI: 10.1161/CIR.0000000000000525. View

Cheng J, den Uil C, Hoeks S, van der Ent M, Jewbali L, van Domburg R . Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009; 30(17):2102-8. DOI: 10.1093/eurheartj/ehp292. View

10.

Saxena A, Garan A, Kapur N, ONeill W, Lindenfeld J, Pinney S . Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation. 2020; 141(14):1184-1197. DOI: 10.1161/CIRCULATIONAHA.119.043080. View

11.

Dangas G, Kini A, Sharma S, Henriques J, Claessen B, Dixon S . Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014; 113(2):222-8. DOI: 10.1016/j.amjcard.2013.09.008. View

12.

Fraccaro C, Teles R, Tchetche D, Saia F, Bedogni F, Montorfano M . Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results. Catheter Cardiovasc Interv. 2020; 96(5):1128-1135. DOI: 10.1002/ccd.29112. View

13.

Karami M, Eriksen E, Ouweneel D, Claessen B, Vis M, Baan J . Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021; 10(9):1009-1015. PMC: 8648392. DOI: 10.1093/ehjacc/zuab060. View

14.

Anderson M, Goldstein J, Milano C, Morris L, Kormos R, Bhama J . Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015; 34(12):1549-60. DOI: 10.1016/j.healun.2015.08.018. View

15.

Tang G, Estevez-Loureiro R, Yu Y, Prillinger J, Zaid S, Psotka M . Survival Following Edge-to-Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis. J Am Heart Assoc. 2021; 10(8):e019882. PMC: 8174169. DOI: 10.1161/JAHA.120.019882. View

16.

Burkhoff D, Cohen H, Brunckhorst C, ONeill W . A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006; 152(3):469.e1-8. DOI: 10.1016/j.ahj.2006.05.031. View

17.

Eckman P, Katz J, El Banayosy A, Bohula E, Sun B, van Diepen S . Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician. Circulation. 2019; 140(24):2019-2037. DOI: 10.1161/CIRCULATIONAHA.119.034512. View

18.

Jung R, Simard T, Kovach C, Flint K, Don C, Di Santo P . Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis. JACC Cardiovasc Interv. 2020; 14(1):1-11. DOI: 10.1016/j.jcin.2020.08.037. View

19.

den Uil C, Akin S, Jewbali L, Dos Reis Miranda D, Brugts J, Constantinescu A . Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017; 52(1):14-25. DOI: 10.1093/ejcts/ezx088. View

20.

Dhruva S, Ross J, Mortazavi B, Hurley N, Krumholz H, Curtis J . Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA. 2020; 323(8):734-745. PMC: 7042879. DOI: 10.1001/jama.2020.0254. View